These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3314257)

  • 41. Gamma interferon modifies CD4+ subset expression in murine candidiasis.
    Romani L; Cenci E; Mencacci A; Spaccapelo R; Grohmann U; Puccetti P; Bistoni F
    Infect Immun; 1992 Nov; 60(11):4950-2. PubMed ID: 1356933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral immunization of mice against candidiasis.
    Jensen J; Warner T; Johnson C; Balish E
    J Infect Dis; 1996 Jul; 174(1):133-40. PubMed ID: 8655983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disparate requirement for T cells in resistance to mucosal and acute systemic candidiasis.
    Jones-Carson J; Vazquez-Torres A; Warner T; Balish E
    Infect Immun; 2000 Apr; 68(4):2363-5. PubMed ID: 10722645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antigenic variability between Candida albicans blastospores isolated from healthy subjects and patients with Candida infection.
    Poulain D; Tronchin G; Lefebvre B; Husson MO
    Sabouraudia; 1982 Sep; 20(3):173-7. PubMed ID: 6753187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Candida and AIDS: evidence for protective antibody.
    Matthews R; Burnie J; Smith D; Clark I; Midgley J; Conolly M; Gazzard B
    Lancet; 1988 Jul; 2(8605):263-6. PubMed ID: 2899245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of a novel delayed-type hypersensitivity assay to Candida albicans in adult and neonatal rats.
    Thorn M; Hudson AW; Kreeger J; Kawabe TT; Bowman CJ; Collinge M
    J Immunotoxicol; 2015; 12(4):350-60. PubMed ID: 25412622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host.
    Tavares D; Salvador A; Ferreira P; Arala-Chaves M
    Infect Immun; 1993 May; 61(5):1881-8. PubMed ID: 8478077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.
    Ibrahim AS; Spellberg BJ; Avenissian V; Fu Y; Filler SG; Edwards JE
    Infect Immun; 2005 Feb; 73(2):999-1005. PubMed ID: 15664943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2.
    Vilanova M; Teixeira L; Caramalho I; Torrado E; Marques A; Madureira P; Ribeiro A; Ferreira P; Gama M; Demengeot J
    Immunology; 2004 Mar; 111(3):334-42. PubMed ID: 15009435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis.
    Garner RE; Domer JE
    Infect Immun; 1994 Feb; 62(2):738-41. PubMed ID: 7507901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunity to Candida albicans induced by Listeria monocytogenes.
    Marra S; Balish E
    Infect Immun; 1974 Jul; 10(1):72-82. PubMed ID: 4210334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.
    Domer JE; Garner RE; Befidi-Mengue RN
    Infect Immun; 1989 Mar; 57(3):693-700. PubMed ID: 2917780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidiasis.
    Quindós G; Pontón J; Cisterna R
    Eur J Clin Microbiol; 1987 Apr; 6(2):142-6. PubMed ID: 3297681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of intrinsic and acquired immune cells infiltration in kidney and spleen of the mice infected with systemic candidiasis and treated with chloroform fraction of Zataria Multiflora Boiss.
    Bayat M; Hassannejad N; Ghazanfari H
    Microb Pathog; 2018 Jan; 114():444-448. PubMed ID: 29183758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of antigen used in the detection of anti-Candida albicans antibodies.
    Garcia-de-Lomas J; Nogueira JM; Buesa FJ; Prat J; Mir A; Moreno F; Gea A
    Mycopathologia; 1985 Oct; 92(1):23-9. PubMed ID: 3906404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serologic analysis of antigen-specific reactivity in patients with systemic candidiasis.
    Au-Young JK; Troy FA; Goldstein E
    Diagn Microbiol Infect Dis; 1985 Sep; 3(5):419-32. PubMed ID: 2411467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the antigen specific to the mycelial phase of Candida albicans in the serodiagnosis of candidiasis.
    Umenai T; Chiba H
    Tohoku J Exp Med; 1977 Dec; 123(4):395-6. PubMed ID: 75594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor protein.
    Londono LP; Jones HB; Vie AT; McPheat WL; Booth G; Gao XM; Dougan G
    FEMS Immunol Med Microbiol; 2000 Feb; 27(2):117-25. PubMed ID: 10640606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antigenic diagnosticum for determining antibodies in candidiasis].
    Lebedeva TN
    Lab Delo; 1981; (10):620-1. PubMed ID: 6170799
    [No Abstract]   [Full Text] [Related]  

  • 60. Immune responses to Candida albicans in genetically distinct mice.
    Hector RF; Domer JE; Carrow EW
    Infect Immun; 1982 Dec; 38(3):1020-8. PubMed ID: 6759403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.